What is Viridian Therapeutics, Inc.'s license — total revenues?

Viridian Therapeutics, Inc. (VRDN) reported license — total revenues of $6K in Q1 2026.

What does license — total revenues mean?

This metric represents the total gross revenue generated specifically from licensing agreements, intellectual property rights, or technology transfer arrangements within the company's portfolio. It reflects the monetization of proprietary assets through partnerships rather than direct product sales. Monitoring this figure helps investors assess the company's ability to extract value from its research and development pipeline through strategic collaborations.

Viridian Therapeutics, Inc. VRDN License — Total revenues

Other product segments

Collaboration

$135K—

Similar metrics at other companies

OTEXLicense — Total revenues

$145.09M+4.9%

INTALicense — Total revenues

$24.79M-21.7%

RYTMLicense revenue — Total revenues

$0+100%

DLBLicensing — Total Revenue

$372.25M+7.6%

BCRXLicense and other revenues — Total revenues

$5.01M+187%

ACIWLicense — Revenue

$88.04M+4.2%

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s license — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s license — total revenues?: Viridian Therapeutics, Inc. (VRDN) reported license — total revenues of $6K in Q1 2026.
What does license — total revenues mean?: This metric represents the total gross revenue generated specifically from licensing agreements, intellectual property rights, or technology transfer arrangements within the company's portfolio. It reflects the monetization of proprietary assets through partnerships rather than direct product sales. Monitoring this figure helps investors assess the company's ability to extract value from its research and development pipeline through strategic collaborations.